摘要 |
The present invention relates to novel 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives according to Formula (I) the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. In particular are claimed compounds according to Formula (I) in which A-B is C-O or SO<SUB>2</SUB>, X is a covalent bond, R<SUP>1 </SUP>is alkyloxy, alkyloxyalkyl, Ar or NR<SUP>9</SUP>R<SUP>10</SUP>, wherein R<SUP>9 </SUP>and R<SUP>10 </SUP>each independently are hydrogen or Ar; or A-B and R<SUP>1 </SUP>together form a benzoxazolyl radical; p is zero, R<SUP>3 </SUP>is benzyl optionally substituted with hydroxy, alkyl or alkyloxycarbonyl and R<SUP>4 </SUP>and R<SUP>5 </SUP>each are hydrogen. The invention also relates to processes for the preparation of the compounds according to the invention and their use in medicine, in particular as selective non-peptide delta-opioid agonists for use in the treatment of various pain conditions.
|